Le Lézard
Classified in: Health
Subject: LBR

TEAMSTERS LOCAL 777 REACHES TENTATIVE AGREEMENTS WITH VERANO CANNABIS


Union Continues Successful Campaign to Bring MSOs Under Contract

CHICAGO, July 20, 2023 /PRNewswire/ -- Teamsters Local 777 has reached tentative agreements for cannabis consultants and agents-in-charge at Zen Leaf dispensaries in Chicago and Schaumburg, Ill. Zen Leaf's parent company, Verano, is the third Multi-state Operator (MSO) that Local 777 has successfully bargained agreements with after launching a campaign to organize the cannabis industry less than three years ago.

"This contract includes monumental improvements that the workers on this committee fought incredibly hard to achieve, and it's been a pleasure working alongside such a dynamic, energetic, brilliant, and tenacious group of trade unionists," said Jim Glimco, President of Local 777. "If past is prologue, the future of the Chicago cannabis industry belongs to us."

Improvements included in the agreement include wage increases ranging from 17 to 20 percent over the next three years, paid time off, employer-funded retirement contributions, overtime allocated by seniority, and the replacement of "at-will" employment with a just process for addressing disciplinary matters.

"This contract is a guidebook on the various ways that MSOs can create a prosperous environment for their workforce, thereby incentivizing long-term careers in this business and reducing the loss of talent," said Peter Finn, Teamsters Western Region International Vice President and Director of the Teamsters Food Processing Division. "We look forward to bargaining similar agreements with the other big players in cannabis."

The Zen Leaf workers will vote on ratifying the two contracts within the next two weeks.

Founded in 1937, Teamsters Local 777 represents workers in a wide variety of industries throughout the Chicago area. For more information, go to teamsters777.org/.

Contact:
Matt McQuaid, (202) 624-6877
[email protected]

SOURCE Teamsters Local 777


These press releases may also interest you

at 06:58
Key takeaways The projected cumulative cost of mental health inequities is estimated to amount to $14 trillion by the year 2040.The U.S. currently spends an estimated $477.5 billion annually in avoidable and unnecessary expenses related to mental...

at 06:50
Merck , known as MSD outside of the United States and Canada, today announced that new data for four approved oncology medicines and four pipeline candidates in more than 25 types of cancer will be presented at the 2024 American Society of Clinical...

at 06:50
The company behind the hormone-free contraceptive Phexxi® (lactic acid, citric acid and potassium bitartrate), Evofem Biosciences, Inc. ("Evofem" or "the Company") today announced financial results for the first quarter of 2024. Highlights of and...

at 06:45
BD (Becton, Dickinson and Company) , a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) approval for the use of self-collected vaginal specimens for human papillomavirus (HPV) testing when cervical...

at 06:30
First quarter revenue of $5.8 million reflects an increase of 59% over fourth quarter of 2023 primarily resulting from an increase in B2B2C revenues and reflects a decrease of 18.5% compared to the first quarter of 2023 due to milestone driven...

at 06:25
FinalSpark, a pioneering Swiss biocomputing startup, has launched the first-ever online platform enabling global researchers to conduct experiments remotely on biological neurons in vitro. The platform provides around-the-clock access to 16 human...



News published on and distributed by: